Trade of the Day: AbbVie (ABBV)

InvestorPlace - Stock Market News, Stock Advice & Trading Tips In 2017, Humira r.....»»

AbbVie Inc. (ABBV) discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company was created in 2013, when Abbott Laboratories split into two companies – Abbvie and Abbott. Abbvie.....»»

On CNBC's "Fast Money Halftime Report," Jim Cramer advised a viewer to stay long in AbbVie Inc (NYSE: ABBV). He loves the stock and the yield. read more.....»»

Related Stocks: ABBV,.....»»

Related Stocks: ABT, TSLA, ABBV, EBAY, ULTA, GILD, ALXN, MO, IVZ, BPOP, MNST,.....»»

Related Stocks: ABBV, MSFT, FCN, KDP,.....»»

The Price And Volume Action In AbbVie's Stock Today AbbVie (NYSE:ABBV) is currently down 5.54% to a price of $104.49. The stock's volume is currently 6.90 million, which is roughly 99.43% of its recent 30-day volume average of 6.94 million. read more.....»»

AbbVie (NYSE:ABBV) shares experienced unusual options activity on Wednesday. The stock price moved up to $103.37 following the option alert. read more.....»»

Despite the pandemic risk, one analyst at Morgan Stanley remains bullish on AbbVie Inc (NYSE: ABBV). The AbbVie Analyst David Risinger maintained an Overweight on AbbVie with a $95 price target.  Lates.....»»

AbbVie (NYSE: ABBV) shares are trading higher on Monday. L.....»»

The deal for AbbVie Inc. to buy Allergan Plc. has cleared an antitrust hurdle, the companies said late Tuesday. The U.S. Federal Trade Commission has accepted a proposed consent order in connection with the pending acquisition, satisfying "all.....»»

InvestorPlace - Stock Market News, Stock Advice & Trading Tips AbbVie (ABBV) earnings f.....»»

The pharmaceutical giant reported strong earnings results thanks to diverse offeringsRelated Stocks: ABBV,.....»»

Shares of AbbVie (NYSE:ABBV) rose 1% in pre-market trading after the comp.....»»

Shares of AbbVie (NYSE:ABBV) rose 1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 13.08% over the past year to $2.42, which beat the estimate of $2.25. read more.....»»

AbbVie Inc (NYSE: ABBV) shares already discount much of the risk emanating from the COVID-19 crisis, according to an analyst at RBC Capital Markets. .....»»

AbbVie tops the listRelated Stocks: ABBV, ANTM, SMG,.....»»

AbbVie makes the listRelated Stocks: ABBV, APO, DHT, TKC, AQN,.....»»

Jim Cramer said on CNBC's "Mad Money Lightning Round" AbbVie Inc (NYSE: ABBV) traded lower on COVID-19, but he likes its dividend yield and it remains a great stock. read more.....»»

Activist Investor Makes New Push for HC2 Board to Remove Chief Falcone: Letter (Reuters) BOSTON (Reuters) – An activist investor .....»»